Michael Vasconcelles has been named the chief medical officer of Cambridge, MA-based cellular immunotherapy startup Unum Therapeutics. Vasconcelles was previously the head of oncology at Takeda Pharmaceuticals. Unum, meanwhile, raised a $65 million Series B round in June to lay the foundation for a future IPO.
From Our Editors · Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities
From Our Editors · Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace
